price
JA
NASDAQ · JANX
Janux Therapeutics, Inc.
Healthcare · Biotechnology
$17.10
Down-$0.58 (-3.28%)
Updated Sep 13, 2026, 4:42 AM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 922.65M
- P/E ratio
- -9.34
- Dividend yield
- 0.00%
- 52-week range
- $12.12 – $35.34
- Volume
- 791.6K
- Avg. volume
- 1.45M
Price performance
JANX price history
1M range · 19 trading sessions · Daily adjusted prices
JANX closed at $17.10 after 19 trading sessions, up 5.17% for the selected period.
- Last close
- $17.10
- Period change
- +5.17%
- Period low
- $16.26
- Period high
- $20.24
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $17.92 | $17.94 | $17.05 | $17.10 | 791.6K |
| Sep 10, 2026 | $19.17 | $19.33 | $17.60 | $17.68 | 980.2K |
| Sep 9, 2026 | $19.94 | $20.225 | $19.27 | $19.33 | 575.98K |
| Sep 8, 2026 | $20.24 | $20.25 | $19.67 | $20.04 | 1.06M |
| Sep 4, 2026 | $19.62 | $20.31 | $19.57 | $20.24 | 700.77K |
| Sep 3, 2026 | $19.73 | $20.00 | $19.52 | $19.80 | 1.69M |
| Sep 2, 2026 | $18.93 | $19.95 | $18.93 | $19.70 | 1.53M |
| Sep 1, 2026 | $18.15 | $18.935 | $18.04 | $18.89 | 980.54K |
| Aug 31, 2026 | $17.89 | $18.39 | $17.66 | $18.22 | 712.59K |
| Aug 28, 2026 | $18.57 | $18.725 | $17.97 | $18.03 | 637.81K |
| Aug 27, 2026 | $19.00 | $19.08 | $18.68 | $18.78 | 577.34K |
| Aug 26, 2026 | $18.59 | $18.95 | $18.33 | $18.89 | 524K |
| Aug 25, 2026 | $18.72 | $19.14 | $18.55 | $18.68 | 1.07M |
| Aug 24, 2026 | $17.82 | $19.025 | $17.50 | $18.60 | 1.45M |
| Aug 21, 2026 | $17.40 | $17.6999 | $17.21 | $17.39 | 520.04K |
| Aug 20, 2026 | $17.29 | $17.64 | $17.19 | $17.28 | 1.12M |
| Aug 19, 2026 | $17.21 | $17.72 | $16.96 | $17.52 | 914.23K |
| Aug 18, 2026 | $16.21 | $16.99 | $16.10 | $16.96 | 583.18K |
| Aug 17, 2026 | $16.07 | $16.37 | $15.93 | $16.26 | 540.81K |
Latest JANX news
The latest Smart Investors Daily articles mentioning JANX.
Stock researchResearch & News · SEC Filings
Loading stock research…

